Test Price
2,800 AEDโ Home Collection Available
CLMP Gene Congenital Short-Bowel Syndrome Genetic Test in UAE
Executive Summary & Core Metrics
Accuracy Guarantee: 99.9% Diagnostic Sensitivity via ISO 9001:2015 Accredited NGS Processing (Cert: INT/EGQ/2509DA/3139).
Premium Logistics: VIP Mobile Phlebotomy & Temperature-Controlled Cold-Chain Home Collection (Available daily from 8 AM to 11 PM) or secure courier for extracted DNA and FTA cards.
Clinical Guidance: Telephonic Post-Test Clinical Guidance in result interpretation with a genetic counsellor.
Insurance: Direct Billing Verification via WhatsApp +971 54 548 8731. All UAE payers accepted.
Test Overview & Methodology
This targeted Next-Generation Sequencing (NGS) analysis examines the entire coding region of the CLMP gene to detect pathogenic variants responsible for congenital short-bowel syndrome, a severe neonatal dysmorphology disorder. The test is performed at DNA Labs UAE, a Dubai Healthcare City facility licensed under DHA License 1143.
| Feature | Our CLMP NGS Test | Closest Alternative (WES/Generic Panel) |
|---|---|---|
| Diagnostic Precision | 99.9% sensitivity; full gene coverage with >200x depth | May have incomplete CLMP coverage or lower depth; risk of false negatives |
| Methodology | Targeted NGS + Sanger confirmation | Whole-exome sequencing with incidental findings; unfocused |
| Turnaround Time | 3โ4 weeks | Often 6โ10 weeks plus additional validation |
| Clinical Relevance | Specific report for short-bowel syndrome, including ACMG classification | May miss or misinterpret rare CLMP variants due to limited focus |
Physician Insight & Safety Protocols
"As a Consultant Medical Genetics specialist, I emphasize that this CLMP gene test provides critical molecular confirmation for congenital short-bowel syndrome, but it must always be interpreted alongside the child's clinical presentation, surgical history, and nutritional status. A genetic result alone is never sufficient to change management without multidisciplinary consultation. Expectant families should be counseled on the nuances of incomplete penetrance and variable expressivity before testing."
โ Lina Osama Zaki Quteineh, Consultant Medical Genetics, DHA Registration ID: 9294403
Advisory โ Medication and Nutritional Continuity
Do not discontinue prescribed medication or nutritional support without consulting your doctor. This test does not replace immediate medical management.
Exclusion Criteria & Emergency Red Flags
- Exclusion: This test is not indicated for asymptomatic individuals without a clinical suspicion of short-bowel syndrome. Samples collected on FTA cards must meet quality standards; hemolyzed, clotted, or insufficient specimens will be rejected.
- Exclusion: Patients experiencing acute, life-threatening gastrointestinal emergencies (e.g., massive bowel infarction, toxic megacolon) should prioritise emergency surgical intervention over elective genetic testing.
- ER Red Flag: If your child develops sudden severe dehydration, electrolyte imbalances, intractable vomiting, or bowel obstruction symptoms during the testing window, seek immediate medical attention at the nearest emergency department.
Patient FAQ & Clinical Guidance
1. What is the CLMP gene and how does it relate to congenital short-bowel syndrome?
The CLMP gene encodes a transmembrane protein essential for intestinal development; pathogenic variants cause congenital short-bowel syndrome with severe malabsorption, failure to thrive, and dependence on parenteral nutrition. This test identifies such variants to confirm the diagnosis.
2. What sample types are accepted and how does the collection process work?
We accept whole blood (EDTA), extracted DNA, or a single drop of blood on an FTA card. For whole blood and FTA, our VIP Mobile Phlebotomy team can collect at your home between 8 AM and 11 PM using temperature-controlled cold-chain logistics. Extracted DNA can be sent via secure medical courier.
3. How long does it take to receive results and who explains them?
The clinical report is delivered within 3 to 4 weeks. You will receive a postโtest telephonic consultation with a genetic counsellor to interpret the findings and discuss next steps for your childโs care.
4. Is this test covered by insurance in the UAE?
We support direct billing for most UAE insurance plans. Please WhatsApp +971 54 548 8731 to verify your coverage before testing.
UAE Regulatory & Data Privacy Adherence
Data Protection & Compliance
This laboratory service strictly adheres to:
- Federal Decree-Law No. 45 of 2021 on Personal Data Protection (PDPL)
- Federal Law No. 2 of 2019 Concerning the Use of Information and Communication Technology in Health Fields
- Federal Decree-Law No. 4 of 2016 on Medical Liability
All genetic information is stored and processed locally within the UAE. ISO 9001:2015 Certified (Cert: INT/EGQ/2509DA/3139).
Clinical & Logistical Metadata
| Test Name | CLMP Gene Congenital Short-Bowel Syndrome Genetic Test |
| Price (AED) | 2,800 AED |
| Turnaround Time | 3โ4 weeks |
| Sample Type / Matrix | Whole blood (EDTA), extracted DNA, or FTA card |
| Methodology Used | Targeted NGS + Sanger confirmation |
| ICD-10-CM Code | Q41.9 โ Congenital absence, atresia and stenosis of small intestine, unspecified |
| LOINC Code | 21636-3 โ Gene analysis in tissue by Molecular genetics method |
| DHA Facility License & Address | License 1143 โ Premises 105, Floor 1, Building 33, Dubai Healthcare City, Dubai, UAE | DNA Labs UAE |
ุฏุนู ุซูุงุฆู ุงููุบุฉ ู ุชุงุญ
ุงูุชุญูู ู ู ุงูุชุบุทูุฉ ุงูุชุฃู ูููุฉ
Check Insurance Coverage Instantly
Stop the guesswork. Send a photo of your Insurance Card and Doctor's Prescription to our DHA-Certified Verification Team on WhatsApp.
ุชููู ุนู ุงูุชุฎู ูู. ุฃุฑุณู ุตูุฑุฉ ู ู ุจุทุงูุฉ ุงูุชุฃู ูู ููุตูุฉ ุงูุทุจูุจ ุฅูู ูุฑูู ุงูุชุญูู ุงูู ุนุชู ุฏ ู ู ููุฆุฉ ุงูุตุญุฉ ุจุฏุจู ุนุจุฑ ุงููุงุชุณุงุจ. ุงุญุตู ุนูู ุชุญุฏูุซ ุงูุญุงูุฉ ูู ุฏูุงุฆู.
Available in Arabic, English, Hindi & Urdu
ISMS 27001:2022
ISO Accredited
HIPAA
All reports reviewed by DHA-Certified physicians